Milestone Pharmaceuticals receives Nasdaq noncompliance notice over minimum bid price
MIST•Milestone Pharmaceuticals received a Nasdaq notice after its shares closed below the $1 minimum bid price for 30 consecutive business days. The company has until April 21, 2027, to regain compliance by closing at or above $1 for 10 consecutive business days.
1. Compliance deadline
The notice, received October 23, 2026, does not immediately affect Milestone Pharmaceuticals’ Nasdaq Global Select Market listing. The company may be eligible to transfer to the Nasdaq Capital Market for additional time, and a reverse stock split remains an option; failure to comply could lead to a delisting notice, which it could appeal.
